학술논문
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
Document Type
Article
Author
Pignata, S; Lorusso, D; Joly, F; Gallo, C; Colombo, N; Sessa, C; Bamias, A; Salutari, V; Selle, F; Frezzini, S; De Giorgi, U; Pautier, P; Bologna, A; Orditura, M; Dubot, C; Gadducci, A; Mammoliti, S; Ray-Coquard, I; Zafarana, E; Breda, E; Favier, L; Ardizzoia, A; Cinieri, S; Largillier, R; Sambataro, D; Guardiola, E; Lauria, R; Pisano, C; Raspagliesi, F; Scambia, G; Daniele, G; Perrone, F; Pignata, Sandro ; Lorusso, Domenica; Joly, Florence; Gallo, Ciro; Colombo, Nicoletta; Sessa, Cristiana; Bamias, Aristotelis; Salutari, Vanda; Selle, Frédèric; Frezzini, Simona; De Giorgi, Ugo; Pautier, Patricia; Bologna, Alessandra; Orditura, Michele; Dubot, Coraline; Gadducci, Angiolo; Mammoliti, Serafina; Ray-Coquard, Isabelle; Zafarana, Elena; Breda, Enrico; Favier, Laure; Ardizzoia, Antonio; Cinieri, Saverio; Largillier, Rémy; Sambataro, Daniela; Guardiola, Emmanuel; Lauria, Rossella; Pisano, Carmela; Raspagliesi, Francesco; Scambia, Giovanni; Daniele, Gennaro; Perrone, Francesco
Source
In The Lancet Oncology February 2021 22(2):267-276
Subject
Language
ISSN
1470-2045